• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠六氯苯卟啉症作为人类慢性肝卟啉症的模型

Hexachlorobenzene porphyria in rats as a model for human chronic hepatic porphyrias.

作者信息

Doss M, Schermuly E, Koss G

出版信息

Ann Clin Res. 1976;8 Suppl 17:171-81.

PMID:1008488
Abstract
  1. Hexachlorobenzene porphyria in the rat provides a suitable experimental model of the stages of development of human chronic hepatic porphyria. Just as in chronic hepatic porphyria in man, the development of experimental HCB porphyria in the rat can be divided into several stages. 2. The findings in this study indicate that porphyrins increase in the urine, liver, kidney, and spleen, and to a lesser degree in the serum, with uroporphyrin and heptacarboxylic porphyrin predominating. 3. In contrast to the distribution of porphyrin accumulation in the various organs, clear evidence of a uroporphyrinogen decarboxylase defect was found only in the liver. Formation of uroporphyrin and heptacarboxylic porphyrin by homogenized HCB kidney tissue did not deviate significantly from that by control kidney. The defect could not be unequivocally evaluated in the spleen because the spleen, like the red cells, normally forms considerable amounts of uroporphyrin from porphobilinogen, which were increased only a few times over in synthesis by the HCB spleen. 4. Isomer studies provide no evidence for an additional uroporphyrinogen cosynthase defect.
摘要
  1. 大鼠六氯苯卟啉症为人类慢性肝卟啉症发展阶段提供了合适的实验模型。正如人类慢性肝卟啉症一样,大鼠实验性六氯苯卟啉症的发展可分为几个阶段。2. 本研究结果表明,卟啉在尿液、肝脏、肾脏和脾脏中增加,在血清中增加程度较小,以尿卟啉和七羧基卟啉为主。3. 与卟啉在各器官中的积累分布不同,仅在肝脏中发现了尿卟啉原脱羧酶缺陷的确切证据。六氯苯处理的肾脏组织匀浆形成尿卟啉和七羧基卟啉的情况与对照肾脏相比无明显差异。脾脏中该缺陷无法明确评估,因为脾脏与红细胞一样,通常由胆色素原形成大量尿卟啉,六氯苯处理的脾脏合成的尿卟啉仅增加了几倍。4. 异构体研究没有提供额外的尿卟啉原合酶缺陷的证据。

相似文献

1
Hexachlorobenzene porphyria in rats as a model for human chronic hepatic porphyrias.大鼠六氯苯卟啉症作为人类慢性肝卟啉症的模型
Ann Clin Res. 1976;8 Suppl 17:171-81.
2
Accumulation of uroporphyrin does not provoke further inhibition of liver uroporphyrinogen decarboxylase activity in hexachlorobenzene-induced porphyria.在六氯苯诱导的卟啉症中,尿卟啉的积累不会进一步抑制肝脏尿卟啉原脱羧酶的活性。
IARC Sci Publ. 1986(77):467-9.
3
[Influence of p-amino-benzoic acid on the hexachlorobenzene induced porphyria in the rat (author's transl)].
Arzneimittelforschung. 1980;30(5):817-21.
4
[Study of the origin of urinary porphyrins in experimental hexachlorobenzene-induced porphyria ].[实验性六氯苯诱导的卟啉病中尿卟啉起源的研究]
Biull Eksp Biol Med. 1990 Apr;109(4):355-7.
5
Studies on the mechanism of uroporphyrinogen decarboxylase inhibition in hexachlorobenzene-induced porphyria in the female rat.
Toxicol Appl Pharmacol. 1997 Jul;145(1):23-33. doi: 10.1006/taap.1997.8157.
6
The use of the rat in the experimental investigation of the porphyrias.大鼠在卟啉症实验研究中的应用。
J S Afr Vet Assoc. 1978 Sep;49(3):249-51.
7
Iron and uroporphyrin in hepatocytes of inbred mice in experimental porphyria: a biochemical and morphological study.实验性卟啉症近交系小鼠肝细胞中的铁与尿卟啉:一项生化与形态学研究
Hepatology. 1991 Dec;14(6):1179-88.
8
Immunochemical studies of the uroporphyrinogen decarboxylase defect caused by hexachlorobenzene.由六氯苯引起的尿卟啉原脱羧酶缺陷的免疫化学研究。
IARC Sci Publ. 1986(77):441-8.
9
Influence of N-acetylcysteine on the hexachlorobenzene induced porphyria in rats.N-乙酰半胱氨酸对六氯苯诱导的大鼠卟啉症的影响。
Arzneimittelforschung. 1985;35(4):713-5.
10
Porphyrins and porphyrinogen carboxy-lase in hexachlorobenzene-induced porphyria.六氯苯诱导的卟啉症中的卟啉和卟啉原羧化酶
Biochem J. 1977 Dec 15;168(3):393-400. doi: 10.1042/bj1680393.

引用本文的文献

1
Environmental chemical exposures and disturbances of heme synthesis.环境化学物质暴露与血红素合成紊乱
Environ Health Perspect. 1997 Feb;105 Suppl 1(Suppl 1):37-53. doi: 10.1289/ehp.97105s137.
2
Effects of oral thalidomide on rat liver and skin microsomal P450 isozyme activities and on urinary porphyrin excretion: interaction with oral hexachlorobenzene.
Arch Dermatol Res. 1994;286(6):347-9. doi: 10.1007/BF00402227.
3
Pathobiochemical transition of secondary coproporphyrinuria to chronic hepatic porphyria in humans.人类继发性粪卟啉尿症向慢性肝卟啉症的病理生化转变。
Klin Wochenschr. 1980 Feb 1;58(3):141-8. doi: 10.1007/BF01477271.
4
Studies on the toxicology of hexachlorobenzene. V. Different phases of porphyria during and after treatment.六氯苯的毒理学研究。V. 治疗期间及治疗后的卟啉症不同阶段
Arch Toxicol. 1983 Jan;52(1):13-22. doi: 10.1007/BF00317978.
5
Vinyl chloride-induced hepatic coproporphyrinuria with transition to chronic hepatic porphyria.氯乙烯诱导的肝粪卟啉尿症并转变为慢性肝卟啉症。
Klin Wochenschr. 1984 Feb 15;62(4):175-8. doi: 10.1007/BF01731640.
6
[Long time HCB exposition of rats: influence on the porphyrin excretion in the urine and on the cytochrome P-450 in the liver (author's transl)].
Arch Dermatol Res (1975). 1977 Aug 22;259(2):199-206. doi: 10.1007/BF00557961.
7
[Hexachlorbenzene (HCB) induced porphyria in rats. Influence of HCB-metabolites on the biosynthesis of heme (author's transl)].[六氯苯(HCB)诱导大鼠卟啉症。HCB代谢产物对血红素生物合成的影响(作者译)]
Arch Dermatol Res. 1978 Nov 10;263(2):189-96. doi: 10.1007/BF00446440.
8
Cutaneous cytochrome P-450 activity during hexachlorobenzene-induced experimental porphyria in rats.六氯苯诱导大鼠实验性卟啉症期间的皮肤细胞色素P-450活性
Arch Dermatol Res. 1979 May 29;265(1):111-4. doi: 10.1007/BF00412708.